|
ZBTB25 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.668800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.723800E-01 |
| Normal-vs-Stage2 |
6.201200E-01 |
| Normal-vs-Stage3 |
8.359000E-01 |
| Normal-vs-Stage4 |
4.735800E-01 |
| Stage1-vs-Stage2 |
9.307800E-01 |
| Stage1-vs-Stage3 |
4.691200E-01 |
| Stage1-vs-Stage4 |
7.780400E-01 |
| Stage2-vs-Stage3 |
5.209600E-01 |
| Stage2-vs-Stage4 |
8.575600E-01 |
| Stage3-vs-Stage4 |
4.452200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.529800E-01 |
| Normal-vs-AfricanAmerican |
6.031000E-01 |
| Normal-vs-Asian |
9.729400E-01 |
| Caucasian-vs-AfricanAmerican |
6.495800E-01 |
| Caucasian-vs-Asian |
7.274400E-01 |
| AfricanAmerican-vs-Asian |
8.214800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.639400E-01 |
| Normal-vs-Female |
4.932100E-02 |
| Male-vs-Female |
4.383800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.488200E-01 |
| Normal-vs-Extreme_Weight |
7.497000E-01 |
| Normal-vs-Obese |
7.469800E-02 |
| Normal-vs-Extreme_Obese |
7.939800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.626400E-01 |
| Normal_Weight-vs-Obese |
1.987170E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.000800E-01 |
| Extreme_Weight-vs-Obese |
1.212760E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.157000E-01 |
| Obese-vs-Extreme_Obese |
2.642200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.744300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.245900E-02 |
| Normal-vs-Age(61-80Yrs) |
8.474600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.951780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.287600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.025900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.630200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.978770E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.945700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.826000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.184200E-01 |
| Normal-VS-Type2 PRCC |
2.760800E-01 |
| Normal-VS-KIRP CIMP |
1.839170E-01 |
| Normal-VS-Unclassified PRCC |
1.953390E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.241700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.944200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.354000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.886250E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.986100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.851000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.853200E-01 |
| Normal-vs-N1 |
3.123800E-01 |
| Normal-vs-N2 |
2.293400E-01 |
| N0-vs-N1 |
2.183600E-01 |
| N0-vs-N2 |
2.861400E-01 |
| N1-vs-N2 |
2.063400E-01 |
|
|
